首页 > 最新文献

Cancer Investigation最新文献

英文 中文
Prognostic Significance of Combining Cytokeratin-19, E-Cadherin and Ki-67 Analysis in Triple-Negative Breast Cancer with Basal-Like and Non-Basal-Like Phenotype. 结合细胞角蛋白-19、E-Cadherin 和 Ki-67 分析对具有基底样和非基底样表型的三阴性乳腺癌的预后意义
IF 1.8 4区 医学 Q3 ONCOLOGY Pub Date : 2024-10-01 Epub Date: 2024-10-22 DOI: 10.1080/07357907.2024.2416166
Zahra Klayech, Adnene Moussa, Moufida Souid, Rim Hadhri, Souad Miled, Sallouha Gabbouj, Yassmine Remadi, Raja Faleh, Noureddine Bouaouina, Abdelfattah Zakhama, Elham Hassen

Triple-negative breast cancer (TNBC) is known to have the worst outcome compared to the other forms of breast cancer. Moreover, molecular markers identified basal-like breast cancer (BLBC) phenotypes to be also related to a worse prognosis. In this study, we evaluated by immunohistochemistry (IHC) the prognostic significance of combining Cytokeratin-19 (CK19), E-cadherin, and Ki-67 tissue expression in triple-negative breast cancer (TNBC) cases presenting a basal-like (BLBC) or a non-basal-like (n-BLBC) phenotype to improve the selection and the monitoring of BC patients with a more aggressive outcome. Herein, when compared to n-BLBC, patients with BLBC showed a positive correlation with lymph node metastasis occurrence and lower survival rates. Immunohistochemistry analysis revealed significantly lower E-cadherin prevalence and higher prevalence of both CK19 and Ki-67 in BLBC when compared to n-BLBC. Spearman correlation showed that E-cadherin is negatively and significantly correlated to CK19 and Ki-67 expressions. Moreover, in BLBC, expressing both CK19 and Ki-67 combined with E-cadherin loss was associated with the worst relapse-free and overall survival. In conclusion, TNBC/BLBC phenotypes simultaneously losing E-cadherin and overexpressing CK19 and Ki-67 markers are the most aggressive forms. This combined analysis could be a predictive marker of poor prognosis.

众所周知,与其他形式的乳腺癌相比,三阴性乳腺癌(TNBC)的预后最差。此外,分子标记物发现基底样乳腺癌(BLBC)表型也与预后较差有关。在这项研究中,我们通过免疫组织化学(IHC)评估了在出现基底样(BLBC)或非基底样(n-BLBC)表型的三阴性乳腺癌(TNBC)病例中结合细胞角蛋白-19(CK19)、E-cadherin 和 Ki-67 组织表达的预后意义,以改进对具有侵袭性预后的 BC 患者的选择和监测。在这里,与n-BLBC相比,BLBC患者与淋巴结转移的发生呈正相关,生存率较低。免疫组化分析显示,与n-BLBC相比,BLBC的E-cadherin含量明显较低,而CK19和Ki-67的含量均较高。斯皮尔曼相关性表明,E-cadherin与CK19和Ki-67的表达呈显著负相关。此外,在BLBC中,同时表达CK19和Ki-67以及E-cadherin缺失与最差的无复发和总生存率相关。总之,同时失去E-cadherin和过表达CK19和Ki-67标记物的TNBC/BLBC表型最具侵袭性。这种综合分析可作为预后不良的预测指标。
{"title":"Prognostic Significance of Combining Cytokeratin-19, E-Cadherin and Ki-67 Analysis in Triple-Negative Breast Cancer with Basal-Like and Non-Basal-Like Phenotype.","authors":"Zahra Klayech, Adnene Moussa, Moufida Souid, Rim Hadhri, Souad Miled, Sallouha Gabbouj, Yassmine Remadi, Raja Faleh, Noureddine Bouaouina, Abdelfattah Zakhama, Elham Hassen","doi":"10.1080/07357907.2024.2416166","DOIUrl":"10.1080/07357907.2024.2416166","url":null,"abstract":"<p><p>Triple-negative breast cancer (TNBC) is known to have the worst outcome compared to the other forms of breast cancer. Moreover, molecular markers identified basal-like breast cancer (BLBC) phenotypes to be also related to a worse prognosis. In this study, we evaluated by immunohistochemistry (IHC) the prognostic significance of combining Cytokeratin-19 (CK19), E-cadherin, and Ki-67 tissue expression in triple-negative breast cancer (TNBC) cases presenting a basal-like (BLBC) or a non-basal-like (n-BLBC) phenotype to improve the selection and the monitoring of BC patients with a more aggressive outcome. Herein, when compared to n-BLBC, patients with BLBC showed a positive correlation with lymph node metastasis occurrence and lower survival rates. Immunohistochemistry analysis revealed significantly lower E-cadherin prevalence and higher prevalence of both CK19 and Ki-67 in BLBC when compared to n-BLBC. Spearman correlation showed that E-cadherin is negatively and significantly correlated to CK19 and Ki-67 expressions. Moreover, in BLBC, expressing both CK19 and Ki-67 combined with E-cadherin loss was associated with the worst relapse-free and overall survival. In conclusion, TNBC/BLBC phenotypes simultaneously losing E-cadherin and overexpressing CK19 and Ki-67 markers are the most aggressive forms. This combined analysis could be a predictive marker of poor prognosis.</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":" ","pages":"769-781"},"PeriodicalIF":1.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142458698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of First-Line Platinum-Based Doublet Chemotherapy in Advanced Primary Pulmonary Salivary Gland Tumors (PSGTs). 晚期原发性肺唾液腺肿瘤(PSGTs)一线铂基双联化疗的有效性和安全性
IF 1.8 4区 医学 Q3 ONCOLOGY Pub Date : 2024-10-01 Epub Date: 2024-09-16 DOI: 10.1080/07357907.2024.2399046
Zheng Shi, Xiaohong Zeng, Wei Sun, Manyi Xu, Keda Shao, Jingwen Wei, Chunwei Xu, Zhengbo Song

Primary pulmonary salivary gland tumors (PSGT) constitute a rare subtype of non-small cell lung cancer (NSCLC). Currently, no established treatment guidelines exist for advanced PSGT. The efficacy of platinum-based chemotherapy for PSGT within the context of NSCLC remains uncertain. Therefore, we retrospectively collected 37 PSGT patients who underwent first-line platinum-based chemotherapy from 2010 to 2023. Survival analysis, employing the Kaplan-Meier method, and group comparisons via the log rank test were conducted. Our results show that first-line platinum-based chemotherapy demonstrates favorable efficacy and manageable safety in advanced PSGT, with the combination of Paclitaxel + Platinum emerging as a preferred option.

原发性肺唾液腺肿瘤(PSGT)是非小细胞肺癌(NSCLC)的一种罕见亚型。目前,还没有针对晚期肺唾液腺肿瘤的既定治疗指南。以铂类为基础的化疗对 NSCLC 中的 PSGT 的疗效仍不确定。因此,我们回顾性地收集了2010年至2023年期间接受一线铂类化疗的37例PSGT患者。我们采用 Kaplan-Meier 法进行了生存期分析,并通过对数秩检验进行了分组比较。我们的研究结果表明,一线铂类化疗对晚期PSGT具有良好的疗效和可控的安全性,紫杉醇+铂类联合化疗成为首选方案。
{"title":"Efficacy and Safety of First-Line Platinum-Based Doublet Chemotherapy in Advanced Primary Pulmonary Salivary Gland Tumors (PSGTs).","authors":"Zheng Shi, Xiaohong Zeng, Wei Sun, Manyi Xu, Keda Shao, Jingwen Wei, Chunwei Xu, Zhengbo Song","doi":"10.1080/07357907.2024.2399046","DOIUrl":"10.1080/07357907.2024.2399046","url":null,"abstract":"<p><p>Primary pulmonary salivary gland tumors (PSGT) constitute a rare subtype of non-small cell lung cancer (NSCLC). Currently, no established treatment guidelines exist for advanced PSGT. The efficacy of platinum-based chemotherapy for PSGT within the context of NSCLC remains uncertain. Therefore, we retrospectively collected 37 PSGT patients who underwent first-line platinum-based chemotherapy from 2010 to 2023. Survival analysis, employing the Kaplan-Meier method, and group comparisons via the log rank test were conducted. Our results show that first-line platinum-based chemotherapy demonstrates favorable efficacy and manageable safety in advanced PSGT, with the combination of Paclitaxel + Platinum emerging as a preferred option.</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":" ","pages":"793-800"},"PeriodicalIF":1.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142280524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of Antiperspirant Products and Risk of Breast Cancer: A Meta-Analysis of Case-Control Studies. 使用止汗剂产品与乳腺癌风险:病例对照研究的元分析》(Meta-Analysis of Case-Control Studies)。
IF 1.8 4区 医学 Q3 ONCOLOGY Pub Date : 2024-10-01 Epub Date: 2024-09-26 DOI: 10.1080/07357907.2024.2405864
Thao Thi Kim Trinh, Seung-Kwon Myung, Tien Hoang Tran, Kui Son Choi

Although several observational studies have reported a link between the use of underarm cosmetic products and the risk of breast cancer, the findings remain inconsistent. This study aimed to investigate these associations using a meta-analysis of observational studies. In the meta-analysis of seven case-control studies, we found no association between the use of underarm antiperspirants or deodorants and the risk of breast cancer (OR = 0.96, 95%CI 0.78-1.17; I2 = 60.0%). Further prospective cohort studies that provide a higher level of evidence are warranted to confirm our findings.

虽然有多项观察性研究报告了使用腋下化妆品与乳腺癌风险之间的联系,但研究结果仍不一致。本研究旨在通过对观察性研究进行荟萃分析来调查这些关联。在对七项病例对照研究进行的荟萃分析中,我们发现使用腋下止汗剂或除臭剂与乳腺癌风险之间没有关联(OR = 0.96,95%CI 0.78-1.17;I2 = 60.0%)。为了证实我们的研究结果,有必要进一步开展前瞻性队列研究,以提供更高水平的证据。
{"title":"Use of Antiperspirant Products and Risk of Breast Cancer: A Meta-Analysis of Case-Control Studies.","authors":"Thao Thi Kim Trinh, Seung-Kwon Myung, Tien Hoang Tran, Kui Son Choi","doi":"10.1080/07357907.2024.2405864","DOIUrl":"10.1080/07357907.2024.2405864","url":null,"abstract":"<p><p>Although several observational studies have reported a link between the use of underarm cosmetic products and the risk of breast cancer, the findings remain inconsistent. This study aimed to investigate these associations using a meta-analysis of observational studies. In the meta-analysis of seven case-control studies, we found no association between the use of underarm antiperspirants or deodorants and the risk of breast cancer (OR = 0.96, 95%CI 0.78-1.17; <i>I</i><sup>2</sup> = 60.0%). Further prospective cohort studies that provide a higher level of evidence are warranted to confirm our findings.</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":" ","pages":"782-792"},"PeriodicalIF":1.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142342181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence in Cancer Clinical Research: IV. Inherent Limitations of Artificial Intelligence. 癌症临床研究中的人工智能:IV.人工智能固有的局限性。
IF 1.8 4区 医学 Q3 ONCOLOGY Pub Date : 2024-10-01 Epub Date: 2024-10-11 DOI: 10.1080/07357907.2024.2412449
Gary H Lyman, Nicole M Kuderer
{"title":"Artificial intelligence in Cancer Clinical Research: IV. Inherent Limitations of Artificial Intelligence.","authors":"Gary H Lyman, Nicole M Kuderer","doi":"10.1080/07357907.2024.2412449","DOIUrl":"10.1080/07357907.2024.2412449","url":null,"abstract":"","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":" ","pages":"741-744"},"PeriodicalIF":1.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142399493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Flamingo Search Sailfish Optimizer Based SqueezeNet for Detection of Breast Cancer Using MRI Images. 基于 Flamingo Search Sailfish Optimizer 的 SqueezeNet 利用核磁共振成像检测乳腺癌。
IF 1.8 4区 医学 Q3 ONCOLOGY Pub Date : 2024-10-01 Epub Date: 2024-09-20 DOI: 10.1080/07357907.2024.2403088
P Vijaya, Satish Chander, Roshan Fernandes, Anisha P Rodrigues, Maheswari Raja

Breast cancer with increased risk in women is identified with Breast Magnetic Resonance Imaging (Breast MRI) and this helps in evaluating treatment therapies. Breast MRI is time time-consuming process that involves the assessment of current imaging. This research work depends on the detection of breast cancer at the earlier stages. Among various cancers, breast cancer in women occurs in larger accounts for almost 30% of estimated cancer cases. In this research, many steps are followed for breast cancer detection like pre-processing, segmentation, augmentation, extraction of features, and cancer detection. Here, the median filter is utilized for pre-processing, as well as segmentation is followed after pre-processing, which is done by Psi-Net. Moreover, the process of augmentation like shearing, translation, and cropping are followed after segmentation. Also, the segmented image tends to process feature extraction, where features like shape features, Completed Local Binary Pattern (CLBP), Pyramid Histogram of Oriented Gradients (PHOG), and statistical features are extracted. Finally, breast cancer is detected using the DL model, SqueezeNet. Here, the newly devised Flamingo Search SailFish Optimizer (FSSFO) is used in training Psi-Net as well as SqueezeNet. Furthermore, FSSFO is the combination of both the Flamingo Search Algorithm (FSA) and SailFish Optimizer (SFO).

通过乳腺磁共振成像(Breast Magnetic Resonance Imaging,简称MRI)可确定女性患乳腺癌的风险,并有助于评估治疗方法。乳腺磁共振成像是一个耗时的过程,涉及对当前成像的评估。这项研究工作取决于能否在早期阶段发现乳腺癌。在各种癌症中,女性乳腺癌的发病率较高,几乎占癌症病例总数的 30%。在这项研究中,乳腺癌检测需要遵循许多步骤,如预处理、分割、增强、特征提取和癌症检测。在这里,预处理采用了中值滤波器,预处理后采用 PsiNet 进行分割。此外,分割后还会进行剪切、平移和裁剪等增强处理。此外,分割后的图像还需要进行特征提取,提取形状特征、完成局部二进制模式(CLBP)、定向梯度金字塔直方图(PHOG)和统计特征。最后,使用 DL 模型 SqueezeNet 检测乳腺癌。在这里,新设计的 Flamingo Search SailFish Optimizer(FSSFO)被用于训练 PsiNet 和 SqueezeNet。此外,FSSFO 是弗拉明戈搜索算法(FSA)和帆鱼优化器(SFO)的结合。
{"title":"Flamingo Search Sailfish Optimizer Based SqueezeNet for Detection of Breast Cancer Using MRI Images.","authors":"P Vijaya, Satish Chander, Roshan Fernandes, Anisha P Rodrigues, Maheswari Raja","doi":"10.1080/07357907.2024.2403088","DOIUrl":"10.1080/07357907.2024.2403088","url":null,"abstract":"<p><p>Breast cancer with increased risk in women is identified with Breast Magnetic Resonance Imaging (Breast MRI) and this helps in evaluating treatment therapies. Breast MRI is time time-consuming process that involves the assessment of current imaging. This research work depends on the detection of breast cancer at the earlier stages. Among various cancers, breast cancer in women occurs in larger accounts for almost 30% of estimated cancer cases. In this research, many steps are followed for breast cancer detection like pre-processing, segmentation, augmentation, extraction of features, and cancer detection. Here, the median filter is utilized for pre-processing, as well as segmentation is followed after pre-processing, which is done by Psi-Net. Moreover, the process of augmentation like shearing, translation, and cropping are followed after segmentation. Also, the segmented image tends to process feature extraction, where features like shape features, Completed Local Binary Pattern (CLBP), Pyramid Histogram of Oriented Gradients (PHOG), and statistical features are extracted. Finally, breast cancer is detected using the DL model, SqueezeNet. Here, the newly devised Flamingo Search SailFish Optimizer (FSSFO) is used in training Psi-Net as well as SqueezeNet. Furthermore, FSSFO is the combination of both the Flamingo Search Algorithm (FSA) and SailFish Optimizer (SFO).</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":" ","pages":"745-768"},"PeriodicalIF":1.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142280525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Relationship Between Body Image and Meaning of Life Among Women with Breast Cancer in Kerman, Iran. 伊朗克尔曼患乳腺癌妇女的身体形象与生活意义之间的关系。
IF 1.8 4区 医学 Q3 ONCOLOGY Pub Date : 2024-09-01 Epub Date: 2024-08-07 DOI: 10.1080/07357907.2024.2371369
Mina Mahmoodabadi, Zohreh Khoshnood, Behjat Kalantari Khandani

We aimed to examine the relationship between body image and the meaning of life among women with breast cancer. The analytic sample included 142 women with breast cancer, and data were collected using a standardized questionnaire through face-to-face interviews. We used Kolmogorov-Smirnov test, Pearson test, Spearman and Mann-Whitney U test to determine the relationship between the research variables. We found an association between the mean score of body image and the mean score of the meaning of life. As the average score of body image increases, the score of the meaning of life increases (p < 0.05). Findings indicated that the body image score increases by increasing the score of the meaning of life and its dimensions, especially existential vacuum and acceptance of death. Future research and targeted treatments should consider the role of body image in shaping the meaning of life among women with breast cancer.

我们旨在研究乳腺癌女性患者的身体形象与生命意义之间的关系。分析样本包括 142 名乳腺癌女性患者,通过面对面访谈,使用标准化问卷收集数据。我们使用了 Kolmogorov-Smirnov 检验、Pearson 检验、Spearman 检验和 Mann-Whitney U 检验来确定研究变量之间的关系。我们发现身体形象的平均得分与生活意义的平均得分之间存在关联。随着身体形象平均得分的增加,生命意义得分也随之增加(p
{"title":"The Relationship Between Body Image and Meaning of Life Among Women with Breast Cancer in Kerman, Iran.","authors":"Mina Mahmoodabadi, Zohreh Khoshnood, Behjat Kalantari Khandani","doi":"10.1080/07357907.2024.2371369","DOIUrl":"10.1080/07357907.2024.2371369","url":null,"abstract":"<p><p>We aimed to examine the relationship between body image and the meaning of life among women with breast cancer. The analytic sample included 142 women with breast cancer, and data were collected using a standardized questionnaire through face-to-face interviews. We used Kolmogorov-Smirnov test, Pearson test, Spearman and Mann-Whitney U test to determine the relationship between the research variables. We found an association between the mean score of body image and the mean score of the meaning of life. As the average score of body image increases, the score of the meaning of life increases (<i>p</i> < 0.05). Findings indicated that the body image score increases by increasing the score of the meaning of life and its dimensions, especially existential vacuum and acceptance of death. Future research and targeted treatments should consider the role of body image in shaping the meaning of life among women with breast cancer.</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":" ","pages":"682-689"},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141896781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TTYH3 Promotes Cervical Cancer Progression by Activating the Wnt/β-Catenin Signaling Pathway. TTYH3通过激活Wnt/β-Catenin信号通路促进宫颈癌进展
IF 1.8 4区 医学 Q3 ONCOLOGY Pub Date : 2024-09-01 Epub Date: 2024-08-27 DOI: 10.1080/07357907.2024.2395014
Xiuyan Huang, Qing Li, Xiaoxia Zheng, Chen Jiang

The role of tweety homolog 3 (TTYH3) has been studied in several cancers, including hepatocellular carcinoma, cholangiocarcinoma, and gastric cancer. The results showed that TTYH3 is highly expression in cervical cancer tissues and cells and high TTYH3 expression correlates with poor prognosis in patients with cervical cancer. TTYH3 markedly reduced the apoptosis rate and promoted proliferation, migration, and invasion. Silencing of TTYH3 has been shown to have an inhibitory effect on cervical cancer progression. Moreover, TTYH3 enhanced EMT and activated Wnt/β-catenin signaling. Furthermore, TTYH3 knockdown inhibited the tumor growth in vivo. In conclusion, TTYH3 promoted cervical cancer progression by activating the Wnt/β-catenin signaling.

有人研究了 Tweety homolog 3(TTYH3)在肝癌、胆管癌和胃癌等多种癌症中的作用。研究结果表明,TTYH3 在宫颈癌组织和细胞中高表达,TTYH3 的高表达与宫颈癌患者的不良预后相关。TTYH3 能显著降低细胞凋亡率,促进细胞增殖、迁移和侵袭。研究表明,沉默 TTYH3 对宫颈癌的进展有抑制作用。此外,TTYH3 还能增强 EMT 并激活 Wnt/β-catenin 信号转导。此外,敲除 TTYH3 可抑制体内肿瘤的生长。总之,TTYH3通过激活Wnt/β-catenin信号促进了宫颈癌的进展。
{"title":"TTYH3 Promotes Cervical Cancer Progression by Activating the Wnt/<b><i>β</i></b>-Catenin Signaling Pathway.","authors":"Xiuyan Huang, Qing Li, Xiaoxia Zheng, Chen Jiang","doi":"10.1080/07357907.2024.2395014","DOIUrl":"10.1080/07357907.2024.2395014","url":null,"abstract":"<p><p>The role of tweety homolog 3 (TTYH3) has been studied in several cancers, including hepatocellular carcinoma, cholangiocarcinoma, and gastric cancer. The results showed that TTYH3 is highly expression in cervical cancer tissues and cells and high TTYH3 expression correlates with poor prognosis in patients with cervical cancer. TTYH3 markedly reduced the apoptosis rate and promoted proliferation, migration, and invasion. Silencing of TTYH3 has been shown to have an inhibitory effect on cervical cancer progression. Moreover, TTYH3 enhanced EMT and activated Wnt/β-catenin signaling. Furthermore, TTYH3 knockdown inhibited the tumor growth in vivo. In conclusion, TTYH3 promoted cervical cancer progression by activating the Wnt/β-catenin signaling.</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":" ","pages":"726-739"},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver Cancer Diagnosis: Enhanced Deep Maxout Model with Improved Feature Set. 肝癌诊断:改进特征集的增强型深度 Maxout 模型
IF 1.8 4区 医学 Q3 ONCOLOGY Pub Date : 2024-09-01 Epub Date: 2024-08-27 DOI: 10.1080/07357907.2024.2391359
Vinnakota Sai Durga Tejaswi, Venubabu Rachapudi

This work proposed a liver cancer classification scheme that includes Preprocessing, Feature extraction, and classification stages. The source images are pre-processed using Gaussian filtering. For segmentation, this work proposes a LUV transformation-based adaptive thresholding-based segmentation process. After the segmentation, certain features are extracted that include multi-texon based features, Improved Local Ternary Pattern (LTP-based features), and GLCM features during this phase. In the Classification phase, an improved Deep Maxout model is proposed for liver cancer detection. The adopted scheme is evaluated over other schemes based on various metrics. While the learning rate is 60%, an improved deep maxout model achieved a higher F-measure value (0.94) for classifying liver cancer; however, the previous method like Support Vector Machine (SVM), Random Forest (RF), Recurrent Neural Network (RNN), Long Short Term Memory (LSTM), K-Nearest Neighbor (KNN), Deep maxout, Convolutional Neural Network (CNN), and DL model holds less F-measure value. An improved deep maxout model achieved minimal False Positive Rate (FPR), and False Negative Rate (FNR) values with the best outcomes compared to other existing models for liver cancer classification.

这项工作提出了一种肝癌分类方案,包括预处理、特征提取和分类三个阶段。使用高斯滤波对源图像进行预处理。在分割方面,这项研究提出了基于 LUV 变换的自适应阈值分割流程。分割完成后,在此阶段将提取某些特征,包括基于多节点的特征、改进的局部三元模式(基于 LTP 的特征)和 GLCM 特征。在分类阶段,提出了一种用于肝癌检测的改进型深度 Maxout 模型。根据各种指标对所采用的方案与其他方案进行了评估。在学习率为 60% 的情况下,改进的 Deep maxout 模型在肝癌分类方面取得了较高的 F-measure 值(0.94);然而,之前的方法,如支持向量机(SVM)、随机森林(RF)、循环神经网络(RNN)、长短期记忆(LSTM)、K-近邻(KNN)、Deep maxout、卷积神经网络(CNN)和 DL 模型的 F-measure 值较低。与其他现有的肝癌分类模型相比,改进后的 Deep maxout 模型的假阳性率(FPR)和假阴性率(FNR)值最小,效果最好。
{"title":"Liver Cancer Diagnosis: Enhanced Deep Maxout Model with Improved Feature Set.","authors":"Vinnakota Sai Durga Tejaswi, Venubabu Rachapudi","doi":"10.1080/07357907.2024.2391359","DOIUrl":"10.1080/07357907.2024.2391359","url":null,"abstract":"<p><p>This work proposed a liver cancer classification scheme that includes Preprocessing, Feature extraction, and classification stages. The source images are pre-processed using Gaussian filtering. For segmentation, this work proposes a LUV transformation-based adaptive thresholding-based segmentation process. After the segmentation, certain features are extracted that include multi-texon based features, Improved Local Ternary Pattern (LTP-based features), and GLCM features during this phase. In the Classification phase, an improved Deep Maxout model is proposed for liver cancer detection. The adopted scheme is evaluated over other schemes based on various metrics. While the learning rate is 60%, an improved deep maxout model achieved a higher <i>F</i>-measure value (0.94) for classifying liver cancer; however, the previous method like Support Vector Machine (SVM), Random Forest (RF), Recurrent Neural Network (RNN), Long Short Term Memory (LSTM), K-Nearest Neighbor (KNN), Deep maxout, Convolutional Neural Network (CNN), and DL model holds less <i>F</i>-measure value. An improved deep maxout model achieved minimal False Positive Rate (FPR), and False Negative Rate (FNR) values with the best outcomes compared to other existing models for liver cancer classification.</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":" ","pages":"710-725"},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cognitive Dysfunction in Non-CNS Metastatic Cancer: Comparing Brain Metastasis, Non-CNS Metastasis, and Healthy Controls. 非中枢神经系统转移性癌症的认知功能障碍:比较脑转移癌、非中枢神经系统转移癌和健康对照组
IF 1.8 4区 医学 Q3 ONCOLOGY Pub Date : 2024-09-01 Epub Date: 2024-07-15 DOI: 10.1080/07357907.2024.2371368
Christopher Collette, Gabrielle Willhelm, Victor A Del Bene, Stephen L Aita, Dario Marotta, Terina Myers, Joseph Anderson, Meredith Gammon, Adam Gerstenecker, L Burt Nabors, John Fiveash, Kristen L Triebel

Limited research has compared cognition of people with non-central nervous system metastatic cancer (NCM) vs. metastatic brain cancer (BM). This prospective cross-sectional study was comprised 37 healthy controls (HC), 40 NCM, and 61 BM completing 10 neuropsychological tests. The NCM performed below HCs on processing speed and executive functioning tasks, while the BM group demonstrated lower performance across tests. Tasks of processing speed, verbal fluency, and verbal memory differentiated the clinical groups (BM < NCM). Nearly 20% of the NCM group was impaired on at least three neuropsychological tests whereas approximately 40% of the BM group demonstrated the same level of impairment.

对非中枢神经系统转移性癌症(NCM)患者与转移性脑癌(BM)患者的认知能力进行比较的研究十分有限。这项前瞻性横断面研究由 37 名健康对照组(HC)、40 名 NCM 和 61 名 BM 组成,他们完成了 10 项神经心理学测试。在处理速度和执行功能任务上,NCM 的表现低于健康对照组,而 BM 组在所有测试中的表现均低于健康对照组。在处理速度、言语流畅性和言语记忆等任务上,临床组(BM 至少完成了三项神经心理学测试,而 BM 组中约 40% 的人表现出了相同程度的障碍)的表现有所区别。
{"title":"Cognitive Dysfunction in Non-CNS Metastatic Cancer: Comparing Brain Metastasis, Non-CNS Metastasis, and Healthy Controls.","authors":"Christopher Collette, Gabrielle Willhelm, Victor A Del Bene, Stephen L Aita, Dario Marotta, Terina Myers, Joseph Anderson, Meredith Gammon, Adam Gerstenecker, L Burt Nabors, John Fiveash, Kristen L Triebel","doi":"10.1080/07357907.2024.2371368","DOIUrl":"10.1080/07357907.2024.2371368","url":null,"abstract":"<p><p>Limited research has compared cognition of people with non-central nervous system metastatic cancer (NCM) <i>vs.</i> metastatic brain cancer (BM). This prospective cross-sectional study was comprised 37 healthy controls (HC), 40 NCM, and 61 BM completing 10 neuropsychological tests. The NCM performed below HCs on processing speed and executive functioning tasks, while the BM group demonstrated lower performance across tests. Tasks of processing speed, verbal fluency, and verbal memory differentiated the clinical groups (BM < NCM). Nearly 20% of the NCM group was impaired on <i>at least</i> three neuropsychological tests whereas approximately 40% of the BM group demonstrated the same level of impairment.</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":" ","pages":"671-681"},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11610445/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141615924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of Invasive Cribriform Carcinoma. 浸润性楔形细胞癌的特征
IF 1.8 4区 医学 Q3 ONCOLOGY Pub Date : 2024-09-01 Epub Date: 2024-07-26 DOI: 10.1080/07357907.2024.2383930
Ryusei Yoshino, Masaki Nakatsubo, Nanami Ujiie, Akane Ito, Nana Yoshida, Masahiro Kitada

Invasive cribriform carcinoma (ICC) is a type of malignant tumor with slow growth and good prognosis. The study was a single center retrospective study. The percentage of ICC among patients diagnosed with breast cancer was 0.3% (8/2454 patients). All patients tested positive for estrogen or progesterone receptors and 12.5% (1/8) patients tested positive for human epidermal growth factor receptor type2 (HER2). The present study suggests that the clinicopathological features of ICC are low-grade hormone receptor-positive luminal type with a good prognosis. However, some patients were HER2-positive and require careful follow-up.

浸润性楔形细胞癌(ICC)是一种生长缓慢、预后良好的恶性肿瘤。该研究是一项单中心回顾性研究。在确诊的乳腺癌患者中,ICC的比例为0.3%(8/2454例)。所有患者的雌激素或孕激素受体检测均呈阳性,12.5%(1/8)的患者人表皮生长因子受体2型(HER2)检测呈阳性。本研究表明,ICC的临床病理特征为低级别激素受体阳性管腔型,预后良好。然而,部分患者为 HER2 阳性,需要仔细随访。
{"title":"Characteristics of Invasive Cribriform Carcinoma.","authors":"Ryusei Yoshino, Masaki Nakatsubo, Nanami Ujiie, Akane Ito, Nana Yoshida, Masahiro Kitada","doi":"10.1080/07357907.2024.2383930","DOIUrl":"10.1080/07357907.2024.2383930","url":null,"abstract":"<p><p>Invasive cribriform carcinoma (ICC) is a type of malignant tumor with slow growth and good prognosis. The study was a single center retrospective study. The percentage of ICC among patients diagnosed with breast cancer was 0.3% (8/2454 patients). All patients tested positive for estrogen or progesterone receptors and 12.5% (1/8) patients tested positive for human epidermal growth factor receptor type2 (HER2). The present study suggests that the clinicopathological features of ICC are low-grade hormone receptor-positive luminal type with a good prognosis. However, some patients were HER2-positive and require careful follow-up.</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":" ","pages":"690-696"},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141757317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cancer Investigation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1